|1.||Kyrova, Kamila: 1 article (01/2014)|
|2.||Elsheimer-Matulova, Marta: 1 article (01/2014)|
|3.||Rychlik, Ivan: 1 article (01/2014)|
|4.||Sun, Ying-Hao: 1 article (11/2013)|
|5.||Zhai, Bei-Bei: 1 article (11/2013)|
|6.||Cao, Zhi: 1 article (11/2013)|
|7.||Qiao, Meng: 1 article (11/2013)|
|8.||Liu, Zhi-Yong: 1 article (11/2013)|
|9.||Wang, Yang: 1 article (11/2013)|
|10.||Yu, Yong-Wei: 1 article (11/2013)|
|1.||Prostatic Neoplasms (Prostate Cancer)
11/01/2013 - "The objectives of this study were to investigate the associations between transglutaminase 4 expression and the established features and biochemical recurrence of prostate cancer. "
11/01/2013 - "Patients with transglutaminase 4 overexpression experienced shorter biochemical recurrence-free survival after surgery (P=0.042) in the univariate analysis but not in the multivariate analysis (P=0.139), which indicated that transglutaminase 4 may serve as a potential predictor of biochemical recurrence of prostate cancer."
11/01/2013 - "We then compared the transglutaminase 4 expression levels between the prostate cancer tissues and the paracarcinoma tissues and evaluated the correlation of transglutaminase 4 expression with the clinical parameters and biochemical recurrence of prostate cancer. "
11/01/2013 - "Transglutaminase 4 has been shown to enhance various biological properties of prostate cancer cells, e.g., cell-matrix adhesion, invasiveness and the epithelial-mesenchymal transition. "
11/01/2013 - "Overexpression of transglutaminase 4 and prostate cancer progression: a potential predictor of less favourable outcomes."
01/01/2014 - "Enteritidis infection include immune responsive gene 1 (IRG1), serum amyloid A (SAA), extracellular fatty acid binding protein (ExFABP), serine protease inhibitor (SERPINB10), trappin 6-like (TRAP6), calprotectin (MRP126), mitochondrial ES1 protein homolog (ES1), interferon-induced protein with tetratricopeptide repeats 5 (IFIT5), avidin (AVD) and transglutaminase 4 (TGM4). "
04/30/2010 - "To gain insight into its role in prostate, we analyzed the expression status of human transglutaminase 4 in benign prostate hyperplasia (BPH) and prostate cancer (PCa). "
04/30/2010 - "Differential alternative splicing of human transglutaminase 4 in benign prostate hyperplasia and prostate cancer."
|1.||Serine Proteases (Serine Protease)
|2.||Leukocyte L1 Antigen Complex (Calgranulin)
|4.||Carrier Proteins (Binding Protein)
|6.||Serum Amyloid A Protein (Serum Amyloid A)
|7.||cyclo(cysteinyl- tyrosyl- norleucyl- glycyl- tryptophyl- cysteinyl)- aspartyl- phenylalaninamide (Es1)